Marksans Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE750C01026
  • NSEID: MARKSANS
  • BSEID: 524404
INR
188.40
11.25 (6.35%)
BSENSE

Feb 09

BSE+NSE Vol: 8.64 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
754.43
720.41
619.99
708.46
681.85
641.92
590.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
754.43
720.41
619.99
708.46
681.85
641.92
590.62
Raw Material Cost
273.82
227.72
192.69
188.08
189.26
214.39
161.31
Purchase of Finished goods
26.99
106.14
171.55
160.96
111.95
134.32
167.24
(Increase) / Decrease In Stocks
15.41
-25.27
-102.43
-23.82
-2.87
-90.31
-66.76
Employee Cost
111.99
103.80
98.39
97.22
88.44
84.16
80.48
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
165.47
163.52
159.67
159.09
156.30
152.55
119.93
Total Expenditure (Excl Depreciation)
593.68
575.91
519.87
581.53
543.08
495.11
462.19
Operating Profit (PBDIT) excl Other Income
160.75
144.50
100.12
126.93
138.77
146.81
128.43
Other Income
20.14
21.57
5.64
15.34
27.85
-0.07
14.95
Operating Profit (PBDIT)
180.89
166.07
105.76
142.27
166.62
146.74
143.38
Interest
5.94
5.82
6.07
3.44
2.67
2.63
2.92
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
174.95
160.25
99.69
138.83
163.95
144.11
140.46
Depreciation
24.33
26.92
23.10
22.74
20.69
19.51
20.44
Profit Before Tax
150.62
133.33
76.60
116.09
143.26
124.60
120.02
Tax
36.93
34.20
18.40
25.37
38.19
26.84
30.95
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
113.69
99.14
58.20
90.73
105.07
97.76
89.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
113.69
99.14
58.20
90.73
105.07
97.76
89.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.49
0.89
-0.12
0.18
0.50
1.04
0.32
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
113.20
98.25
58.32
90.55
104.56
96.72
88.75
Equity Capital
45.32
45.32
45.32
45.32
45.32
45.32
45.32
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
2,236.08
0.00
Earnings per share (EPS)
2.5
2.17
1.29
2.0
2.31
2.13
1.96
Diluted Earnings per share
2.5
2.17
1.29
2.0
2.31
2.13
1.96
Operating Profit Margin (Excl OI)
21.31%
20.06%
16.15%
17.92%
20.35%
22.87%
21.74%
Gross Profit Margin
23.19%
22.24%
16.08%
19.6%
24.04%
22.45%
23.78%
PAT Margin
15.07%
13.76%
9.39%
12.81%
15.41%
15.23%
15.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 4.72% vs 16.20% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 15.22% vs 68.47% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 11.25% vs 44.33% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 2.06% vs -4.12% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Marksans Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
754.43
0
754.43
Other Operating Income
0.00
0.00
0.00
Total Operating income
754.43
0
754.43
Raw Material Cost
273.82
0
273.82
Purchase of Finished goods
26.99
0
26.99
(Increase) / Decrease In Stocks
15.41
0
15.41
Employee Cost
111.99
0
111.99
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
165.47
0.00
165.47
Total Expenditure (Excl Depreciation)
593.68
0
593.68
Operating Profit (PBDIT) excl Other Income
160.75
0.00
160.75
Other Income
20.14
0
20.14
Operating Profit (PBDIT)
180.89
0
180.89
Interest
5.94
0
5.94
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
174.95
0
174.95
Depreciation
24.33
0
24.33
Profit Before Tax
150.62
0
150.62
Tax
36.93
0
36.93
Provisions and contingencies
0.00
0
0.00
Profit After Tax
113.69
0
113.69
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
113.69
0
113.69
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.49
0
0.49
Other related items
0.00
0.00
0.00
Consolidated Net Profit
113.20
0
113.20
Equity Capital
45.32
0
45.32
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
2.50
0
2.50
Diluted Earnings per share
2.50
0
2.50
Operating Profit Margin (Excl OI)
21.31%
0%
0.00
21.31%
Gross Profit Margin
23.19%
0%
0.00
23.19%
PAT Margin
15.07%
0%
0.00
15.07%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 754.43 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 4.72% vs 16.20% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 10.64% vs 16.33% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 113.20 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 15.22% vs 68.47% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 8.26% vs 25.61% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 160.75 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 11.25% vs 44.33% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 15.84% vs 4.32% in Dec 2024

Quarterly - Interest
Interest 5.94 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 2.06% vs -4.12% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 122.47% vs -15.51% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.31%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024